Reporting is likely the process leading to the issue of the PPL, the Financial Advisor has likely made a recommendation which is being internally reviewed by EXIM for a decision and they would be formulating updated terms and conditions at this point, possibly including adjustments from the 402(A) decision.
We're still short of approval by the EXIM board, but I'd say we can expect a good indication in December.
- Forums
- ASX - By Stock
- IBG
- Ann: 2021 Annual General Meeting Presentation
Ann: 2021 Annual General Meeting Presentation, page-6
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBG (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $5.924M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $10.50K | 3.001M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 23725748 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 7397597 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 23059082 | 0.003 |
19 | 13955034 | 0.002 |
6 | 8299989 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 7397597 | 6 |
0.005 | 4300330 | 8 |
0.006 | 4860777 | 2 |
0.007 | 815300 | 4 |
0.008 | 606448 | 3 |
Last trade - 15.55pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
IBG (ASX) Chart |